{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:49:53Z","timestamp":1771912193800,"version":"3.50.1"},"reference-count":61,"publisher":"Japanese Society of Veterinary Science","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1292\/jvms.25-0293","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:08:10Z","timestamp":1761862090000},"page":"1451-1457","source":"Crossref","is-referenced-by-count":1,"title":["A review of the clinical efficacy and adverse effects of disease modifying          osteoarthritic drugs (DMOADs) in dogs with special focus on glucosamine and pentosan          polysulfate; do they work?"],"prefix":"10.1292","volume":"87","author":[{"given":"Eugene C","family":"BWALYA","sequence":"first","affiliation":[{"name":"Department of Clinical Studies, School of Veterinary Medicine, University              of Zambia, Great East Road Main Campus, Lusaka, Zambia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HM Suranji","family":"WIJEKOON","sequence":"additional","affiliation":[{"name":"Nebraska Translational Research Center, Department of Growth and              Development, College of Dentistry, University of Nebraska Medical Center, Omaha, NE,              USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"OKUMURA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Surgery, Department of Veterinary Clinical              Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Hokkaido,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Adams              ME. 1999.            Hype about glucosamine.            <i>Lancet<\/i>          354: 353\u2013354.","DOI":"10.1016\/S0140-6736(99)90040-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ajadi              AR, Gazal              OS, Otesile              EB, Kasali              OB. 2013.            Evaluation of glucosamine and snail mucin on the progression of            experimental knee osteoarthritis in dogs. <i>Res              Artic<\/i>          31: 280.","DOI":"10.4067\/S0717-95022013000100044"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Akermark              C, Crone              H, Elsasser              U, Forssk\u00e5hl              B. 1995.            Glycosaminoglycan polysulfate injections in lateral humeral            epicondylalgia: a placebo-controlled double-blind trial.              <i>Int J Sports Med<\/i>          16: 196\u2013200.","DOI":"10.1055\/s-2007-972991"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Alcaraz              MJ, Meg\u00edas              J,                Garc\u00eda-Arnandis              I, Cl\u00e9rigues              V, Guill\u00e9n              MI. 2010.            New molecular targets for the treatment of          osteoarthritis. <i>Biochem Pharmacol<\/i>          80: 13\u201321.","DOI":"10.1016\/j.bcp.2010.02.017"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Brandt              KD, Mazzuca              SA. 2005.            Lessons learned from nine clinical trials of disease-modifying            osteoarthritis drugs. <i>Arthritis Rheum<\/i>          52: 3349\u20133359.","DOI":"10.1002\/art.21409"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Brandt              KD. 2011.            Why should we expect a structure-modifying osteoarthritis drug to relieve            osteoarthritis pain?<i>Ann Rheum Dis<\/i>          70: 1175\u20131177.","DOI":"10.1136\/ard.2011.150953"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Brandt              KD, Radin              EL, Dieppe              PA, van de                Putte              L. 2006.            Yet more evidence that osteoarthritis is not a cartilage            disease. <i>Ann Rheum Dis<\/i>          65: 1261\u20131264.","DOI":"10.1136\/ard.2006.058347"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Budsberg              SC, Bergh              MS, Reynolds              LR, Streppa              HK. 2007.            Evaluation of pentosan polysulfate sodium in the postoperative recovery            from cranial cruciate injury in dogs: a randomized, placebo-controlled clinical            trial. <i>Vet Surg<\/i>          36: 234\u2013244.","DOI":"10.1111\/j.1532-950X.2007.00256.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Caron              JP, Kaneene              JB, Miller              R. 1996.            Results of a survey of equine practitioners on the use and perceived            efficacy of polysulfated glycosaminoglycan. <i>J Am Vet Med              Assoc<\/i>          209: 1564\u20131568.","DOI":"10.2460\/javma.1996.209.09.1564"},{"key":"10","unstructured":"10. Chamchan              U, Waikakul              S,                Pukanchana-Mo-Rakote              C. 1989.            Clinical efficacy of glycosaminoglycan polysulfate for the treatment of            osteoarthritis of the knee joint: a double blind controlled study.              <i>J Med Assoc Thai<\/i>          72: 123\u2013128."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chan              PS, Caron              JP, Rosa              GJM, Orth              MW. 2005.            Glucosamine and chondroitin sulfate regulate gene expression and            synthesis of nitric oxide and prostaglandin E(2) in articular cartilage            explants. <i>Osteoarthritis Cartilage<\/i>          13: 387\u2013394.","DOI":"10.1016\/j.joca.2005.01.003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chard              J, Dieppe              P. 2001.            Glucosamine for osteoarthritis: magic, hype, or confusion? It\u2019s probably            safe-but there\u2019s no good evidence that it works.              <i>BMJ<\/i>          322: 1439\u20131440.","DOI":"10.1136\/bmj.322.7300.1439"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Clouet              J, Vinatier              C, Merceron              C, Pot-vaucel              M, Maugars              Y, Weiss              P, Grimandi              G, Guicheux              J. 2009.            From osteoarthritis treatments to future regenerative therapies for            cartilage. <i>Drug Discov Today<\/i>          14: 913\u2013925.","DOI":"10.1016\/j.drudis.2009.07.012"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Collier              S, Ghosh              P. 1989.            Evaluation of the effect of antiarthritic drugs on the secretion of            proteoglycans by lapine chondrocytes using a novel assay procedure.              <i>Ann Rheum Dis<\/i>          48: 372\u2013381.","DOI":"10.1136\/ard.48.5.372"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Conaghan              PG, Hunter              DJ,                Maillefert              JF, Reichmann              WM, Losina              E. 2011.            Summary and recommendations of the OARSI FDA osteoarthritis Assessment of            Structural Change Working Group. <i>Osteoarthritis              Cartilage<\/i>          19: 606\u2013610.","DOI":"10.1016\/j.joca.2011.02.018"},{"key":"16","unstructured":"16. Costeseque              R, Emonds-Alt              X, Breliere              JC, Roncucci              R. 1986.            Polysulphated polysaccharides: an in vitro study of their effects on            proteoglycan biosynthesis by articular chondrocytes.              <i>Arch Int Pharmacodyn Ther<\/i>          282: 196\u2013208."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fenton              JI,                Chlebek-Brown              KA, Peters              TL, Caron              JP, Orth              MW. 2000.            Glucosamine HCl reduces equine articular cartilage degradation in explant            culture. <i>Osteoarthritis Cartilage<\/i>          8: 258\u2013265.","DOI":"10.1053\/joca.1999.0299"},{"key":"18","unstructured":"18. Fossum              WT, Hedlund              SC, Johnson              LA, Schulz              SK, Seim              HB              III, et al.            2007. Small Animal Surgery, 3rd ed., Mosby Elsevier, St.          Louis."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fujiki              M, Shineha              J,                Yamanokuchi              K, Misumi              K, Sakamoto              H. 2007.            Effects of treatment with polysulfated glycosaminoglycan on serum            cartilage oligomeric matrix protein and C-reactive protein concentrations, serum matrix            metalloproteinase-2 and -9 activities, and lameness in dogs with            osteoarthritis. <i>Am J Vet Res<\/i>          68: 827\u2013833.","DOI":"10.2460\/ajvr.68.8.827"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ghosh              P. 1999.            The pathobiology of osteoarthritis and the rationale for the use of            pentosan polysulfate for its treatment. <i>Semin Arthritis              Rheum<\/i>          28: 211\u2013267.","DOI":"10.1016\/S0049-0172(99)80021-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gouze              JN, Bordji              K, Gulberti              S, Terlain              B, Netter              P, Magdalou              J,                Fournel-Gigleux              S, Ouzzine              M. 2001.            Interleukin-1beta down-regulates the expression of            glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis:            influence of glucosamine on interleukin-1beta-mediated effects in rat            chondrocytes. <i>Arthritis Rheum<\/i>          44: 351\u2013360.","DOI":"10.1002\/1529-0131(200102)44:2<351::AID-ANR53>3.3.CO;2-D"},{"key":"22","unstructured":"22. Guideline on clinical investigation of medicinal          products used in the treatment of osteoarthritis: http:\/\/search.conduit.com\/ResultsExt.aspx?ctid [accessed on December 4,          2013]."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hannon              RL, Smith              JG,                Cullis-Hill              D, Ghosh              P, Cawdery              MJH. 2003.            Safety of Cartrophen Vet in the dog: review of adverse reaction reports            in the UK. <i>J Small Anim Pract<\/i>          44: 202\u2013208.","DOI":"10.1111\/j.1748-5827.2003.tb00144.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hellio Le                Graverand-Gastineau              MP. 2009.            OA clinical trials: current targets and trials for OA. Choosing molecular            targets: what have we learned and where we are              headed?<i>Osteoarthritis Cartilage<\/i>          17: 1393\u20131401.","DOI":"10.1016\/j.joca.2009.04.009"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Innes              JF, Barr              AR, Sharif              M. 2000.            Efficacy of oral calcium pentosan polysulphate for the treatment of            osteoarthritis of the canine stifle joint secondary to cranial cruciate ligament            deficiency. <i>Vet Rec<\/i>          146: 433\u2013437.","DOI":"10.1136\/vr.146.15.433"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ishikawa              K, Kitagawa              T, Tanaka              T, Terayama              K, Kuriya              N, Iwata              H, Niwa              S, Sakurai              M. 1982.            Clinical testing of intra-articularly injected glycosaminoglycan            polysulfate in gonarthrosis (a controlled multicenter double-blind            study). <i>Z Orthop Ihre Grenzgeb<\/i>          120: 708\u2013716.","DOI":"10.1055\/s-2008-1051383"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Jones              SR, Carley              S, Harrison              M. 2003.            An introduction to power and sample size estimation.              <i>Emerg Med J<\/i>          20: 453\u2013458.","DOI":"10.1136\/emj.20.5.453"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kannus              P, Natri              A, Niittym\u00e4ki              S, J\u00e4rvinen              M. 1992.            Effect of intraarticular glycosaminoglycan polysulfate treatment on            patellofemoral pain syndrome. A prospective, randomized double-blind trial comparing            glycosaminoglycan polysulfate with placebo and quadriceps muscle            exercises. <i>Arthritis Rheum<\/i>          35: 1053\u20131061.","DOI":"10.1002\/art.1780350910"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Krasnokutsky              S, Attur              M, Palmer              G, Samuels              J, Abramson              SB. 2008.            Current concepts in the pathogenesis of osteoarthritis.              <i>Osteoarthritis Cartilage<\/i>          16Suppl 3: S1\u2013S3.","DOI":"10.1016\/j.joca.2008.06.025"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kumagai              K, Shirabe              S, Miyata              N, Murata              M, Yamauchi              A, Kataoka              Y, Niwa              M. 2010.            Sodium pentosan polysulfate resulted in cartilage improvement in knee            osteoarthritis--an open clinical trial. <i>BMC Clin              Pharmacol<\/i>          10: 7.","DOI":"10.1186\/1472-6904-10-7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Leffler              CT, Philippi              AF, Leffler              SG, Mosure              JC, Kim              PD. 1999.            Glucosamine, chondroitin, and manganese ascorbate for degenerative joint            disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot            study. <i>Mil Med<\/i>          164: 85\u201391.","DOI":"10.1093\/milmed\/164.2.85"},{"key":"32","unstructured":"32. MacPhail              CM. 2000.            Treatment of canine osteoarthritis.              <i>Waltham Focus<\/i>          10: 25\u201331."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Martel-Pelletier              J, Wildi              LM, Pelletier              JP. 2012.            Future therapeutics for osteoarthritis.              <i>Bone<\/i>          51: 297\u2013311.","DOI":"10.1016\/j.bone.2011.10.008"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. McCarthy              G, O\u2019Donovan              J, Jones              B, McAllister              H, Seed              M, Mooney              C. 2007.            Randomised double-blind, positive-controlled trial to assess the efficacy            of glucosamine\/chondroitin sulfate for the treatment of dogs with            osteoarthritis. <i>Vet J<\/i>          174: 54\u201361.","DOI":"10.1016\/j.tvjl.2006.02.015"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. McIlwraith              CW, Frisbie              DD, Kawcak              CE. 2012.            Evaluation of intramuscularly administered sodium pentosan polysulfate            for treatment of experimentally induced osteoarthritis in horses.              <i>Am J Vet Res<\/i>          73: 628\u2013633.","DOI":"10.2460\/ajvr.73.5.628"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Meininger              CJ, Kelly              KA, Li              H, Haynes              TE, Wu              G. 2000.            Glucosamine inhibits inducible nitric oxide synthesis.              <i>Biochem Biophys Res Commun<\/i>          279: 234\u2013239.","DOI":"10.1006\/bbrc.2000.3912"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Mendis              E, Kim              MM, Rajapakse              N, Kim              SK. 2008.            Sulfated glucosamine inhibits oxidation of biomolecules in cells via a            mechanism involving intracellular free radical scavenging.              <i>Eur J Pharmacol<\/i>          579: 74\u201385.","DOI":"10.1016\/j.ejphar.2007.10.027"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Moreau              M, Dupuis              J, Bonneau              NH, Desnoyers              M. 2003.            Clinical evaluation of a nutraceutical, carprofen and meloxicam for the            treatment of dogs with osteoarthritis. <i>Vet            Rec<\/i>          152: 323\u2013329.","DOI":"10.1136\/vr.152.11.323"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Munteanu              SE, Ilic              MZ, Handley              CJ. 2000.            Calcium pentosan polysulfate inhibits the catabolism of aggrecan in            articular cartilage explant cultures. <i>Arthritis              Rheum<\/i>          43: 2211\u20132218.","DOI":"10.1002\/1529-0131(200010)43:10<2211::AID-ANR8>3.0.CO;2-D"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Murrell              GA, Jang              D, Williams              RJ. 1995.            Nitric oxide activates metalloprotease enzymes in articular            cartilage. <i>Biochem Biophys Res Commun<\/i>          206: 15\u201321.","DOI":"10.1006\/bbrc.1995.1003"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Nganvongpanit              K,                Pothacharoen              P, Suwankong              N, Ong-Chai              S,                Kongtawelert              P. 2009.            The effect of doxycycline on canine hip osteoarthritis: design of a            6-months clinical trial. <i>J Vet Sci<\/i>          10: 239\u2013247.","DOI":"10.4142\/jvs.2009.10.3.239"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Pavelk\u00e1              K, Gatterov\u00e1              J, Olejarov\u00e1              M, Machacek              S, Giacovelli              G, Rovati              LC. 2002.            Glucosamine sulfate use and delay of progression of knee osteoarthritis:            a 3-year, randomized, placebo-controlled, double-blind study.              <i>Arch Intern Med<\/i>          162: 2113\u20132123.","DOI":"10.1001\/archinte.162.18.2113"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Pavelka              K              Jr, Sedl\u00e1ckov\u00e1              M, Gatterov\u00e1              J, Becv\u00e1r              R, Pavelka              K              Sr          1995. Glycosaminoglycan polysulfuric acid (GAGPS) in            osteoarthritis of the knee. <i>Osteoarthritis              Cartilage<\/i>          3: 15\u201323.","DOI":"10.1016\/S1063-4584(05)80034-2"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Pelletier              JP,                Martel-Pelletier              J, Abramson              SB. 2001.            Osteoarthritis, an inflammatory disease: potential implication for the            selection of new therapeutic targets. <i>Arthritis              Rheum<\/i>          44: 1237\u20131247.","DOI":"10.1002\/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F"},{"key":"45","unstructured":"45. Pelletier              JP, Kapoor              M, Lajeunesse              D, Fahmi              H,                Martel-Pelletier              J. 2012.            Disease Modifying Effect of Strontium Ranelate in Experimental Dog            Osteoarthritis. <i>Inhibition of Major Catabolic Pathways              Arthritis Rheum<\/i>          64Suppl 10: 730."},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Qvist              P, Bay-Jensen              AC,                Christiansen              C, Dam              EB,                Pastoureau              P, Karsdal              MA. 2008.            The disease modifying osteoarthritis drug (DMOAD): Is it in the            horizon?<i>Pharmacol Res<\/i>          58: 1\u20137.","DOI":"10.1016\/j.phrs.2008.06.001"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Railhac              JJ, Zaim              M, Saurel              AS, Vial              J, Fournie              B. 2012.            Effect of 12 months treatment with chondroitin sulfate on cartilage            volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled            pilot study using MRI. <i>Clin Rheumatol<\/i>          31: 1347\u20131357.","DOI":"10.1007\/s10067-012-2022-4"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Read              RA,                Cullis-Hill              D, Jones              MP. 1996.            Systemic use of pentosan polysulphate in the treatment of            osteoarthritis. <i>J Small Anim Pract<\/i>          37: 108\u2013114.","DOI":"10.1111\/j.1748-5827.1996.tb02355.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Reginster              JY, Deroisy              R, Rovati              LC, Lee              RL, Lejeune              E, Bruyere              O, Giacovelli              G, Henrotin              Y, Dacre              JE, Gossett              C. 2001.            Long-term effects of glucosamine sulphate on osteoarthritis progression:            a randomised, placebo-controlled clinical trial.              <i>Lancet<\/i>          357: 251\u2013256.","DOI":"10.1016\/S0140-6736(00)03610-2"},{"key":"50","unstructured":"50. Richard              F, Loeser              J. 2005.            Management of osteoarthritis: can we slow disease            progression?\u202f<i>Rev Art<\/i>          21: 104\u2013106."},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Rogachefsky              RA, Dean              DD, Howell              DS, Altman              RD. 1993.            Treatment of canine osteoarthritis with insulin-like growth factor-1            (IGF-1) and sodium pentosan polysulfate. <i>Osteoarthritis              Cartilage<\/i>          1: 105\u2013114.","DOI":"10.1016\/S1063-4584(05)80025-1"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Sawitzke              AD, Shi              H, Finco              MF, Dunlop              DD, Bingham              CO              3rd, Harris              CL, Singer              NG, Bradley              JD, Silver              D, Jackson              CG, Lane              NE, Oddis              CV, Wolfe              F, Lisse              J, Furst              DE, Reda              DJ, Moskowitz              RW, Williams              HJ, Clegg              DO. 2008.            The effect of glucosamine and\/or chondroitin sulfate on the progression            of knee osteoarthritis: a report from the glucosamine\/chondroitin arthritis intervention            trial. <i>Arthritis Rheum<\/i>          58: 3183\u20133191.","DOI":"10.1002\/art.23973"},{"key":"53","unstructured":"53. Smith              J., Hannon              R. L.,                Brunnberg              L., Gebski              V. and                Cullis-Hill              D.          2002. A multicentre clinical study of the efficacy of sodium            pentosan polysulfate and carprofen in canine osteoarthritis            (osteoarthrosis).            <i>Veterinarmotet<\/i>123\u2013130."},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Sunaga              T, Oh              N, Hosoya              K, Takagi              S, Okumura              M. 2012.            Inhibitory effects of pentosan polysulfate sodium on MAP-kinase pathway            and NF-\u03baB nuclear translocation in canine chondrocytes in vitro.              <i>J Vet Med Sci<\/i>          74: 707\u2013711.","DOI":"10.1292\/jvms.11-0511"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Vangsness              CT              Jr, Spiker              W, Erickson              J. 2009.            A review of evidence-based medicine for glucosamine and chondroitin            sulfate use in knee osteoarthritis.            <i>Arthroscopy<\/i>          25: 86\u201394.","DOI":"10.1016\/j.arthro.2008.07.020"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Varghese              S,                Theprungsirikul              P, Sahani              S, Hwang              N, Yarema              KJ, Elisseeff              JH. 2007.            Glucosamine modulates chondrocyte proliferation, matrix synthesis, and            gene expression. <i>Osteoarthritis            Cartilage<\/i>          15: 59\u201368.","DOI":"10.1016\/j.joca.2006.06.008"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Vaughan-Scott              T, Taylor              JH. 1997.            The pathophysiology and medical management of canine            osteoarthritis. <i>J S Afr Vet Assoc<\/i>          68: 21\u201325.","DOI":"10.4102\/jsava.v68i1.861"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Verde              C, Ferrante              M, Simpson              MI, Babusci              M, Broglia              G, Landoni              MF. 2010.            Efficacy of intramuscular polysulfated glycosaminoglycan in a controlled            study of equine carpitis. <i>J Vet Pharmacol            Ther<\/i>          33: 357\u2013362.","DOI":"10.1111\/j.1365-2885.2009.01154.x"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Wen              ZH, Tang              CC, Chang              YC, Huang              SY, Hsieh              SP, Lee              CH, Huang              GS, Ng              HF, Neoh              CA, Hsieh              CS, Chen              WF, Jean              YH. 2010.            Glucosamine sulfate reduces experimental osteoarthritis and nociception            in rats: association with changes of mitogen-activated protein kinase in            chondrocytes. <i>Osteoarthritis Cartilage<\/i>          18: 1192\u20131202.","DOI":"10.1016\/j.joca.2010.05.012"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Zegels              B, Crozes              P, Uebelhart              D, Bruy\u00e8re              O, Reginster              JY. 2013.            Equivalence of a single dose (1200 mg) compared to a three-time a day            dose (400 mg) of chondroitin 4&amp;6 sulfate in patients with knee osteoarthritis.            Results of a randomized double blind placebo controlled study.              <i>Osteoarthritis Cartilage<\/i>          21: 22\u201327.","DOI":"10.1016\/j.joca.2012.09.017"},{"key":"61","unstructured":"61. Zhong              B. 2009.            How to calculate sample size in randomized controlled            trial?<i>J Thorac Dis<\/i>          1: 51\u201354."}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/12\/87_25-0293\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:41:41Z","timestamp":1764992501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/12\/87_25-0293\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.25-0293","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25-0293"}}